SCHEMBL1740901

SCHEMBL1740901

N=C(N)NC(=N)Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.56
MEN1 O00255 5/20 0.56
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TGM2 P21980 1/20 0.49
NPC1 O15118 3/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 2/20 0.47
MAPK1 P28482 2/20 0.47
POLB P06746 2/20 0.47
NAMPT P43490 1/20 0.47
MITF O75030 1/20 0.47
GAA P10253 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MYOC Q99972 1/20 0.47
LMNA P02545 1/20 0.46
F10 P00742 1/20 0.46
PLAU P00749 1/20 0.46
PLAT P00750 1/20 0.46
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL21645347 0.98 KMT2A (0.54) KMT2AMEN1ALDH1A1SMN1; SMN2TGM2
SCHEMBL11268626 0.89 KMT2A (0.59) KMT2AMEN1ALDH1A1SMN1; SMN2TGM2
SCHEMBL1740370 0.86 KMT2A (0.63) KMT2AMEN1ALDH1A1SMN1; SMN2TGM2
SCHEMBL16470335 0.86 KMT2A (0.68) KMT2AMEN1ALDH1A1SMN1; SMN2TGM2
SCHEMBL11137991 0.85 MEN1 (0.69) KMT2AMEN1SMN1; SMN2TGM2NPC1
Hydrochloric Acid SCHEMBL7258086 0.84 KMT2A (0.61) KMT2AMEN1ALDH1A1SMN1; SMN2TGM2
Hydrochloric Acid SCHEMBL15527542 0.84 KMT2A (0.66) KMT2AMEN1ALDH1A1SMN1; SMN2TGM2
Hydrochloric Acid SCHEMBL4361436 0.84 MEN1 (0.53) KMT2AMEN1ALDH1A1SMN1; SMN2TGM2
Nitric Acid SCHEMBL3860512 0.83 KMT2A (0.59) KMT2AMEN1ALDH1A1SMN1; SMN2TGM2
SCHEMBL3068902 0.82 F2 (0.43) ALDH1A1NPC1RAB9AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180482-B1 MOISTURE-CURABLE COMPOSITION NITTO KASEI CO LTD (JP) 2025-12-03 EP disclosed
US-12479869-B2 Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product NITTO KASEI CO., LTD. (JP) 2025-11-25 US disclosed
EP-4174053-B1 CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT NITTO KASEI CO LTD (JP) 2025-11-19 EP disclosed
EP-4569023-A1 COMBINATION OF CATALYTIC COMPONENTS PolyU GmbH (DE) 2025-06-18 EP disclosed
US-12264275-B2 Treatment liquid FUJIFILM CORPORATION (JP) 2025-04-01 US disclosed
CN-118931673-A Treatment liquid, kit, method for producing treatment liquid, method for cleaning substrate, and method for treating substrate 富士胶片株式会社 2024-11-12 CN disclosed
CN-118931672-A Treatment liquid, kit, method for producing treatment liquid, method for cleaning substrate, and method for treating substrate 富士胶片株式会社 2024-11-12 CN disclosed
CN-115516041-B Curing catalyst for curing polymer, method for producing same, moisture-curable composition, and method for producing cured product 日东化成株式会社 2024-06-28 CN disclosed
WO-2024033348-A1 COMBINATION OF CATALYTIC COMPONENTS POLYU GMBH (DE) 2024-02-15 WO disclosed
EP-4321573-A1 COMBINATION OF CATALYTIC COMPONENTS PolyU GmbH (DE) 2024-02-14 EP disclosed
US-20110237723-A1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF KANEKA CORPORATION (JP) 2011-09-29 US disclosed
CN-102165016-A Curable composition and cured product thereof KANEKA CORP 2011-08-24 CN disclosed
EP-2338938-A1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF Kaneka Corporation (JP) 2011-06-29 EP disclosed
EP-2267083-A1 CURABLE COMPOSITION AND CURED MATERIAL Kaneka Corporation (JP) 2010-12-29 EP disclosed
CN-101503615-A Method for preparing single-component high temperature curing sealing material for ironmaking tuyere of blast furnace WUHAN IRON & STEEL GROUP CORP (CN) 2009-08-12 CN disclosed
CN-100345953-C Rinse-added fabric conditioning composition for use where residual detergent is present PROCTER & GAMBLE (US) 2007-10-31 CN disclosed
CN-1227348-C Rinse-added fabric treatment compositions, kits containing same, and methods of use thereof PROCTER & GAMBLE (US) 2005-11-16 CN disclosed
CN-1659261-A Compositions comprising specfic fabric softener actives PROCTER & GAMBLE (US) 2005-08-24 CN disclosed
CN-1494585-A Rinse-added fabric conditioning composition for use where residual detergent is present 2004-05-05 CN disclosed
CN-1437648-A Rinse-added fabric treatment compositions, kits containing same, and methods of use thereof PROCTER & GAMBLE (US) 2003-08-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12479869-B2 Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product KDM2B, SETDB1, ASH2L KMT2A 150/4885MEN1 684/4885ALDH1A1 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.